x

Facet Team Member Contributes to Recent Pediatric Dermatology Publication

Head of R&D Co-authors Journal Article Wayne, PA, September 19, 2018 – Facet Life Sciences, a leading provider of development software and services for small and growing life sciences teams, today announced the publication of “Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation” in Pediatric [click to read the full story]

Facet Life Sciences Appoints Tobias Massa, Ph.D. to Board of Directors

Seasoned Life Sciences Expert Joins Innovative Development Solution Provider Wayne, PA, September 12, 2017 – Facet Life Sciences, a leading provider of development solutions (software and services) for small and growing life sciences teams, today announced that Tobias Massa, PhD has joined the company’s Board of Directors. Dr. Massa brings [click to read the full story]

PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

LAGUNA HILLS, Calif., Jan. 30, 2017 (GLOBE NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, officially announced today that PharmaCyte has retained Facet Life Sciences, Inc. (Facet) to guide PharmaCyte through [click to read the full story]

Virtual Regulatory Solutions Rebrands as Facet Life Sciences

Innovative Development Solutions Company Rebrands to Reflect Broad Product and Service Offerings Wayne, PA, January 10, 2017 – Virtual Regulatory Solutions, a leading provider of development solutions (software and services) for small and growing life sciences teams, today announced that the company is rebranding under the name, Facet Life Sciences. [click to read the full story]